Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Piret, J.; Boivin, G. Pandemics Throughout History. Front. Microbiol. 2020, 11, 631736. [Google Scholar] [CrossRef]
- Fauci, A.S. Infectious diseases: Considerations for the 21st century. Clin. Infect. Dis. 2001, 32, 675–685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spellberg, B. Dr. William H. Stewart: Mistaken or maligned? Clin. Infect. Dis. 2008, 47, 294. [Google Scholar] [CrossRef] [PubMed]
- Tabish, S.A. Recent trends in emerging infectious diseases. Int. J. Health Sci. 2009, 3, V–VIII. [Google Scholar]
- World Health Organization. A Brief Guide to Emerging Infectious Diseases and Zoonoses. Available online: https://apps.who.int/iris/handle/10665/204722 (accessed on 23 December 2021).
- Wolfe, N.D.; Dunavan, C.P.; Diamond, J. Origins of major human infectious diseases. Nature 2007, 447, 279–283. [Google Scholar] [CrossRef]
- Jones, K.E.; Patel, N.G.; Levy, M.A.; Storeygard, A.; Balk, D.; Gittleman, J.L.; Daszak, P. Global trends in emerging infectious diseases. Nature 2008, 451, 990–993. [Google Scholar] [CrossRef]
- Stephens, P.R.; Gottdenker, N.; Schatz, A.M.; Schmidt, J.P.; Drake, J.M. Characteristics of the 100 largest modern zoonotic disease outbreaks. Philos. Trans. R. Soc. B 2021, 376, 20200535. [Google Scholar] [CrossRef]
- Rahman, M.T.; Sobur, M.A.; Islam, M.S.; Ievy, S.; Hossain, M.J.; El Zowalaty, M.E.; Rahman, A.T.; Ashour, H.M. Zoonotic Diseases: Etiology, Impact, and Control. Microorganisms 2020, 8, 1405. [Google Scholar] [CrossRef]
- McArthur, D.B. Emerging Infectious Diseases. Nurs. Clin. N. Am. 2019, 54, 297–311. [Google Scholar] [CrossRef]
- Peters, A.; Vetter, P.; Guitart, C.; Lotfinejad, N.; Pittet, D. Understanding the emerging coronavirus: What it means for health security and infection prevention. J. Hosp. Infect. 2020, 104, 440–448. [Google Scholar] [CrossRef]
- Coker, R.J.; Hunter, B.M.; Rudge, J.W.; Liverani, M.; Hanvoravongchai, P. Emerging infectious diseases in southeast Asia: Regional challenges to control. Lancet 2011, 377, 599–609. [Google Scholar] [CrossRef]
- Fenollar, F.; Mediannikov, O. Emerging infectious diseases in Africa in the 21st century. New Microbes New Infect. 2018, 26, S10–S18. [Google Scholar] [CrossRef] [PubMed]
- Yeh, K.B.; Parekh, F.K.; Borgert, B.; Olinger, G.G.; Fair, J.M. Global health security threats and related risks in Latin America. Glob. Secur. Health Sci. Policy 2021, 6, 18–25. [Google Scholar] [CrossRef]
- Ogden, N.H.; Gachon, P. Climate change and infectious diseases: What can we expect? Can. Commun. Dis. Rep. 2019, 45, 76–80. [Google Scholar] [CrossRef] [PubMed]
- Caminade, C.; McIntyre, K.M.; Jones, A.E. Impact of recent and future climate change on vector-borne diseases. Ann. N. Y. Acad. Sci. 2019, 1436, 157–173. [Google Scholar] [CrossRef] [Green Version]
- Woolhouse, M.E.; Brierley, L.; McCaffery, C.; Lycett, S. Assessing the Epidemic Potential of RNA and DNA Viruses. Emerg. Infect. Dis. 2016, 22, 2037–2044. [Google Scholar] [CrossRef]
- Poulakou, G.; Bassetti, M.; Timsit, J.F. Critically ill migrants with infection: Diagnostic considerations for intensive care physicians in Europe. Intensive Care Med. 2016, 42, 245–248. [Google Scholar] [CrossRef]
- Fragkou, P.C.; Moschopoulos, C.D.; Karofylakis, E.; Kelesidis, T.; Tsiodras, S. Update in Viral Infections in the Intensive Care Unit. Front. Med. 2021, 8, 575580. [Google Scholar] [CrossRef]
- Mazonakis, N.; Markaki, I.; Spernovasilis, N. How human behavior will lead to the next pandemic. Infect. Control Hosp. Epidemiol. 2021, 1–2. [Google Scholar] [CrossRef]
- Spernovasilis, N.; Markaki, I.; Papadakis, M.; Tsioutis, C.; Markaki, L. Epidemics and pandemics: Is human overpopulation the elephant in the room? Ethics Med. Public Health 2021, 19, 100728. [Google Scholar] [CrossRef]
- Poulakou, G.; Plachouras, D. Planet’s population on the move, infections on the rise. Intensive Care Med. 2016, 42, 2055–2058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. Coronavirus Disease (COVID-19). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed on 23 December 2021).
- Smith, M.P. Estimating total morbidity burden of COVID-19: Relative importance of death and disability. J. Clin. Epidemiol. 2021, 142, 54–59. [Google Scholar] [CrossRef] [PubMed]
- Santomauro, D.F.; Mantilla Herrera, A.M.; Shadid, J.; Zheng, P.; Ashbaugh, C.; Pigott, D.M.; Abbafati, C.; Adolph, C.; Amlag, J.O.; Aravkin, A.Y.; et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021, 398, 1700–1712. [Google Scholar] [CrossRef]
- Wei, X.; Li, L.; Zhang, F. The impact of the COVID-19 pandemic on socio-economic and sustainability. Environ. Sci. Pollut. Res. Int. 2021, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Bastani, H.; Drakopoulos, K.; Gupta, V.; Vlachogiannis, I.; Hadjicristodoulou, C.; Lagiou, P.; Magiorkinis, G.; Paraskevis, D.; Tsiodras, S. Efficient and targeted COVID-19 border testing via reinforcement learning. Nature 2021, 599, 108–113. [Google Scholar] [CrossRef]
- Petala, M.; Kostoglou, M.; Karapantsios, T.; Dovas, C.I.; Lytras, T.; Paraskevis, D.; Roilides, E.; Koutsolioutsou-Benaki, A.; Panagiotakopoulos, G.; Sypsa, V.; et al. Relating SARS-CoV-2 shedding rate in wastewater to daily positive tests data: A consistent model based approach. Sci. Total Environ. 2022, 807, 150838. [Google Scholar] [CrossRef]
- Galani, A.; Aalizadeh, R.; Kostakis, M.; Markou, A.; Alygizakis, N.; Lytras, T.; Adamopoulos, P.G.; Peccia, J.; Thompson, D.C.; Kontou, A.; et al. SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions. Sci. Total Environ. 2022, 804, 150151. [Google Scholar] [CrossRef]
- Subali, A.D.; Wiyono, L.; Yusuf, M.; Zaky, M.F.A. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: A systematic review & meta-analysis. Diagn. Microbiol. Infect. Dis. 2021, 102, 115589. [Google Scholar]
- Diallo, A.; Trøseid, M.; Simensen, V.C.; Boston, A.; Demotes, J.; Olsen, I.C.; Chung, F.; Paiva, J.A.; Hites, M.; Ader, F.; et al. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: Challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Clin. Microbiol. Infect. 2022, 28, 1–5. [Google Scholar] [CrossRef]
- Mallapaty, S.; Callaway, E.; Kozlov, M.; Ledford, H.; Pickrell, J.; Van Noorden, R. How COVID vaccines shaped 2021 in eight powerful charts. Nature 2021, 600, 580–583. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Spernovasilis, N.; Tsiodras, S.; Poulakou, G. Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors. Microorganisms 2022, 10, 98. https://doi.org/10.3390/microorganisms10010098
Spernovasilis N, Tsiodras S, Poulakou G. Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors. Microorganisms. 2022; 10(1):98. https://doi.org/10.3390/microorganisms10010098
Chicago/Turabian StyleSpernovasilis, Nikolaos, Sotirios Tsiodras, and Garyphallia Poulakou. 2022. "Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors" Microorganisms 10, no. 1: 98. https://doi.org/10.3390/microorganisms10010098
APA StyleSpernovasilis, N., Tsiodras, S., & Poulakou, G. (2022). Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors. Microorganisms, 10(1), 98. https://doi.org/10.3390/microorganisms10010098